Global Tuberculosis Vaccine Market Professional Survey Report 2016
- QYR587546
- 173 Pages
- June 2016
- Pharmaceuticals
Mainly covers the following product types
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic
Others
Segment regions including (the separated region report can also be offered)
USA
China
UK
France
India
Japan
Germany
Canada
The players list (Partly, Players you are interested in can also be added)
Sanofi-Pasteur
IDT Biologika
Shenzhen Taikang
Novartis
Squibb
Beijing Tiantan Biological Products
GSK
Shanghai Institute of Biological Products
Chengdu Institute of Biological Products
Abbott
Takeda
Chiron Corporation
Crucell
Intervax Ltd
Japan BCG Laboratory
Serum Institute of India Ltd
Statens Serum Institute
Dainippon Sumitomo Pharma Co., Ltd
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Bottle and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Bottle, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Tuberculosis Vaccine
1.1 Definition and Specifications of Tuberculosis Vaccine
1.1.1 Definition of Tuberculosis Vaccine
1.1.2 Specifications of Tuberculosis Vaccine
1.2 Classification of Tuberculosis Vaccine
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Tuberculosis Vaccine
1.3.1 Hospital use
1.3.2 Clinic
1.3.3 Others
1.4 Industry Chain Structure of Tuberculosis Vaccine
1.5 Industry Overview and Major Regions Status of Tuberculosis Vaccine
1.5.1 Industry Overview of Tuberculosis Vaccine
1.5.2 Global Major Regions Status of Tuberculosis Vaccine
1.6 Industry Policy Analysis of Tuberculosis Vaccine
1.7 Industry News Analysis of Tuberculosis Vaccine
2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine
2.1 Raw Material Suppliers and Price Analysis of Tuberculosis Vaccine
2.2 Equipment Suppliers and Price Analysis of Tuberculosis Vaccine
2.3 Labor Cost Analysis of Tuberculosis Vaccine
2.4 Other Costs Analysis of Tuberculosis Vaccine
2.5 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine
2.6 Manufacturing Process Analysis of Tuberculosis Vaccine
3 Technical Data and Manufacturing Plants Analysis of Tuberculosis Vaccine
3.1 Capacity and Commercial Production Date of Global Tuberculosis Vaccine Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Tuberculosis Vaccine Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Tuberculosis Vaccine Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Tuberculosis Vaccine Major Manufacturers in 2015
4 Global Tuberculosis Vaccine Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Tuberculosis Vaccine Capacity and Growth Rate Analysis
4.2.2 2015 Tuberculosis Vaccine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Tuberculosis Vaccine Sales and Growth Rate Analysis
4.3.2 2015 Tuberculosis Vaccine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Tuberculosis Vaccine Sales Price
4.4.2 2015 Tuberculosis Vaccine Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Tuberculosis Vaccine Gross Margin
4.5.2 2015 Tuberculosis Vaccine Gross Margin Analysis (Company Segment)
5 Tuberculosis Vaccine Regional Market Analysis
5.1 USA Tuberculosis Vaccine Market Analysis
5.1.1 USA Tuberculosis Vaccine Market Overview
5.1.2 USA 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.1.4 USA 2015 Tuberculosis Vaccine Market Share Analysis
5.2 China Tuberculosis Vaccine Market Analysis
5.2.1 China Tuberculosis Vaccine Market Overview
5.2.2 China 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.2.4 China 2015 Tuberculosis Vaccine Market Share Analysis
5.3 UK Tuberculosis Vaccine Market Analysis
5.3.1 UK Tuberculosis Vaccine Market Overview
5.3.2 UK 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.3.4 UK 2015 Tuberculosis Vaccine Market Share Analysis
5.4 France Tuberculosis Vaccine Market Analysis
5.4.1 France Tuberculosis Vaccine Market Overview
5.4.2 France 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.4.4 France 2015 Tuberculosis Vaccine Market Share Analysis
5.5 India Tuberculosis Vaccine Market Analysis
5.5.1 India Tuberculosis Vaccine Market Overview
5.5.2 India 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 India 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.5.4 India 2015 Tuberculosis Vaccine Market Share Analysis
5.6 Japan Tuberculosis Vaccine Market Analysis
5.6.1 Japan Tuberculosis Vaccine Market Overview
5.6.2 Japan 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.6.4 Japan 2015 Tuberculosis Vaccine Market Share Analysis
5.7 Germany Tuberculosis Vaccine Market Analysis
5.7.1 Germany Tuberculosis Vaccine Market Overview
5.7.2 Germany 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Tuberculosis Vaccine Sales Price Analysis
5.7.4 Germany 2015 Tuberculosis Vaccine Market Share Analysis
Canada Tuberculosis Vaccine Market Analysis
.1 Canada Tuberculosis Vaccine Market Overview
.2 Canada 2011-2016E Tuberculosis Vaccine Local Supply, Import, Export, Local Consumption Analysis
.3 Canada 2011-2016E Tuberculosis Vaccine Sales Price Analysis
.4 Canada 2015 Tuberculosis Vaccine Market Share Analysis
6 Global 2011-2016E Tuberculosis Vaccine Segment Market Analysis (by Type)
6.1 Global 2011-2016E Tuberculosis Vaccine Sales by Type
6.2 Different Types Tuberculosis Vaccine Product Interview Price Analysis
6.3 Different Types Tuberculosis Vaccine Product Driving Factors Analysis
6.3.1 Injection Tuberculosis Vaccine Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Tuberculosis Vaccine Growth Driving Factor Analysis
7 Global 2011-2016E Tuberculosis Vaccine Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Tuberculosis Vaccine Growth Driving Factor Analysis
7.3.2 Clinic Tuberculosis Vaccine Growth Driving Factor Analysis
7.3.3 Others Tuberculosis Vaccine Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Tuberculosis Vaccine
8.1 Sanofi-Pasteur
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Sanofi-Pasteur 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Sanofi-Pasteur 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.2 IDT Biologika
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 IDT Biologika 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 IDT Biologika 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.3 Shenzhen Taikang
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Shenzhen Taikang 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Shenzhen Taikang 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Novartis 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.6 Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Squibb 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Squibb 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.8 Beijing Tiantan Biological Products
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Beijing Tiantan Biological Products 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Beijing Tiantan Biological Products 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.9 GSK
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 GSK 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 GSK 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.10 Shanghai Institute of Biological Products
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Shanghai Institute of Biological Products 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Shanghai Institute of Biological Products 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.11 Chengdu Institute of Biological Products
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Chengdu Institute of Biological Products 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Chengdu Institute of Biological Products 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.12 Abbott
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Abbott 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Abbott 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.12 Takeda
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Takeda 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Takeda 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.14 Chiron Corporation
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Chiron Corporation 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Chiron Corporation 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.15 Crucell
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Crucell 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Crucell 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.16 Intervax Ltd
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Intervax Ltd 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Intervax Ltd 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.17 Japan BCG Laboratory
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Japan BCG Laboratory 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Japan BCG Laboratory 2015 Tuberculosis Vaccine Business Region Distribution Analysis
8.18 Serum Institute of India Ltd
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Serum Institute of India Ltd 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Serum Institute of India Ltd 2015 Tuberculosis Vaccine Business Region Distribution Analysis
Statens Serum Institute
.1 Company Profile
.2 Product Picture and Specifications
.3 Statens Serum Institute 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Statens Serum Institute 2015 Tuberculosis Vaccine Business Region Distribution Analysis
Dainippon Sumitomo Pharma Co., Ltd
.1 Company Profile
.2 Product Picture and Specifications
.3 Dainippon Sumitomo Pharma Co., Ltd 2015 Tuberculosis Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Dainippon Sumitomo Pharma Co., Ltd 2015 Tuberculosis Vaccine Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.2 China 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.3 UK 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.4 France 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.5 India 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.6 Japan 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.7 Germany 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.2.9 Canada 2016-2021 Tuberculosis Vaccine Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Tuberculosis Vaccine Marketing Model Analysis
10.1 Tuberculosis Vaccine Regional Marketing Model Analysis
10.2 Tuberculosis Vaccine International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Tuberculosis Vaccine by Regions
10.4 Tuberculosis Vaccine Supply Chain Analysis
11 Consumers Analysis of Tuberculosis Vaccine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Tuberculosis Vaccine
12.1 New Project SWOT Analysis of Tuberculosis Vaccine
12.2 New Project Investment Feasibility Analysis of Tuberculosis Vaccine
13 Conclusion of the Global Tuberculosis Vaccine Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
